Apellis Pharmaceuticals, Inc. financial data

Symbol
APLS on Nasdaq
Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 355% % -18%
Quick Ratio 48% % -30%
Debt-to-equity 245% % -3.5%
Return On Equity 8.2% %
Return On Assets 2.4% %
Operating Margin 5.5% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 127,829,909 shares 1.7%
Common Stock, Shares, Outstanding 126,621,000 shares 1.7%
Entity Public Float $1,800,000,000 USD -57%
Common Stock, Value, Issued $12,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 126,145,000 shares 1.8%
Weighted Average Number of Shares Outstanding, Diluted 129,855,000 shares 4.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,003,782,000 USD 28%
Research and Development Expense $295,854,000 USD -9.7%
Operating Income (Loss) $55,427,000 USD -95%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $24,110,000 USD -63%
Income Tax Expense (Benefit) $1,722,000 USD 48%
Net Income (Loss) Attributable to Parent $22,388,000 USD -62%
Earnings Per Share, Basic 0.18 USD/shares -53%
Earnings Per Share, Diluted 0.2 USD/shares -33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $466,233,000 USD 13%
Accounts Receivable, after Allowance for Credit Loss, Current $366,221,000 USD 38%
Inventory, Net $142,556,000 USD 75%
Other Assets, Current $10,158,000 USD -14%
Assets, Current $1,014,840,000 USD 29%
Property, Plant and Equipment, Net $1,708,000 USD -42%
Operating Lease, Right-of-Use Asset $18,195,000 USD 13%
Other Assets, Noncurrent $5,555,000 USD 312%
Assets $1,075,257,000 USD 21%
Accounts Payable, Current $56,798,000 USD 47%
Accrued Liabilities, Current $166,049,000 USD 18%
Liabilities, Current $323,596,000 USD 74%
Operating Lease, Liability, Noncurrent $11,947,000 USD 17%
Other Liabilities, Noncurrent $7,903,000 USD -0.87%
Liabilities $705,110,000 USD 7.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,103,000 USD 36%
Retained Earnings (Accumulated Deficit) $3,012,978,000 USD 0.74%
Stockholders' Equity Attributable to Parent $370,147,000 USD 62%
Liabilities and Equity $1,075,257,000 USD 21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $53,410,000 USD 60%
Net Cash Provided by (Used in) Financing Activities $108,212,000 USD -72%
Net Cash Provided by (Used in) Investing Activities $8,000 USD 97%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 126,621,000 shares 1.7%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $52,785,000 USD -109%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $467,760,000 USD 13%
Interest Paid, Excluding Capitalized Interest, Operating Activities $11,092,000 USD 575%
Deferred Tax Assets, Valuation Allowance $734,816,000 USD 1.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $738,679,000 USD 1.7%
Operating Lease, Liability $19,034,000 USD 12%
Depreciation $446,000 USD 0.45%
Payments to Acquire Property, Plant, and Equipment $8,000 USD -97%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $23,593,000 USD -61%
Lessee, Operating Lease, Liability, to be Paid $21,026,000 USD 15%
Operating Lease, Liability, Current $7,087,000 USD 4.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,808,000 USD -18%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,940,000 USD 6.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.0652 pure 5.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,992,000 USD 47%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,581,000 USD 52%
Deferred Tax Assets, Operating Loss Carryforwards $306,448,000 USD -2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,324,000 USD 495%
Operating Lease, Payments $2,311,000 USD 14%
Additional Paid in Capital $3,385,216,000 USD 3.6%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%